device_cost, pricing_transparency

An upstart tech startup determined to bring much-needed price transparency to the hospital purchasing environment just got $4 million in Series A funding.

You can count that every dollar will go toward evening out the playing field when it comes to negotiating hospital purchasing agreements of medical devices.

And rightly so, given that hospital executives all the way to the GAO have found price transparency to be conspicuous by its very absence in such negotiations.

That’s where Procured Health, the Chicago startup, comes in. On Thursday, FCA...

March 21st, 2014

The Class I recall of McKesson's Anesthesia Care software provides clues as to what FDA considers to be high-risk clinical decision-support software and high-risk bugs.

By Bradley Merrill Thompson

On March 14, 2014, FDA notified healthcare professionals of a Class I recall that McKesson initiated in 2013 of its Anesthesia Care software. Because FDA rarely issues a recall notice of that nature with regard to standalone software—software that does not play a role in operating a medical device—there are some important insights about FDA’s stance on clinical decision-support software (CDS) that we can derive from its action. 

The recall classification gives us some clues as to what FDA considers to be high-risk clinical decision support software, and high-risk bugs that might be...

March 20th, 2014

A few weeks ago, Aetna CEO Mark Bertolini announced at the annual HIMSS conference that the insurance company was collaborating with medical device maker on heart failure and diabetes.

It’s a novel collaboration and underscores how the healthcare industry is undergoing unprecedented shift. Aetna is of course keen to bend the cost curve of healthcare and manage its own expenses, which necessarily means keeping a handle on chronic diseases such as heart failure and...

March 18th, 2014

There's been a lot of speculation around Apple's plans to enter the healthcare space very soon. Health tracking capabilities built into the iPhone 5's M7 chip, a number of high-profile hires, and rumors of the company developing its own “iWatch” for health monitoring have fanned flames that Apple wants a piece of the mhealth and digital health space.

Recreations of leaked images of Apple's Healthbook app show a variety of health monitoring features. [...
March 17th, 2014

Misconduct in scientific research dates back to Ptolemy in 2nd Century A.D. who declared that he had recorded measurements - which he couldn't possibly have - to show that the earth was at the center of all celestial bodies, including the sun.

But Ptolemy's grand declaration didn't exactly harm anyone. That isn't the case with misconduct in medical research, however.

In fact, orthopedics experts and journal editors at the 81st annual meeting of the American Academy of Orthopaedic Surgeons in New Orleans Wednesday said they are concerned by the fact that misconduct in medical research has been on the rise in recent years.

In 2012, there were 2047...

March 12th, 2014

Incentives are the key to getting patients to engage with connected health devices in a meaningful way.

By Michael Dermer, Welltok Inc.


Weaving medical devices and consumer health technology into our daily lives has great potential to improve the health of our nation, but only if we truly optimize the use of the information tracked and have the right incentives in place to maintain engagement.

There’s no arguing that the connected health movement has reached a tipping point—52% of consumers are interested in buying wearable health trackers, according to the 2014 Accenture Digital Consumer Tech Survey, and...

March 10th, 2014

MIT Technology Review's list of the “50 Smartest Companies 2014” features quite a few medical device and healthcare technology innovators.

The list, compiled by the magazine's editors, is meant to “highlight companies that have displayed impressive innovations in the past year. It is not based on quantitative measures such as patents or R&D spending.”
Second Sight's Argus II retinal prosthesis earned the company a spot on MIT's Smartest Companies list.
Taking the No. 1 spot is Illumina, San Diego-based genome-sequencing company. Illumina's DNA sequencing machines...
March 5th, 2014

By Reade Harpham



Mobile device owners have developed an insatiable appetite for mHealth-related applications. According to industry estimates, by 2015, over half a billion people will be using mHealth apps.

The market has noticed, and to meet demand application developers are cranking out healthcare apps as fast as they can for a variety of uses. Some apps help people manage their own wellness. Others are used by healthcare professionals to access patient electronic health records. And some apps can even control medical devices, or display images and data that can be used by physicians to diagnose and treat disease.Some apps...
March 5th, 2014

quality assurance, quality control

Today's orthopedic practitioner and their technology-driven assets are a far cry from the bone saw wielding image of 100 years ago.

Today's implant surgeons are aided by all types of imagery, robotic assistants, and multiple types of implant devices for any type of knee, hip, spinal, hand or foot procedure that can be conceived. Yet with the operating room containing more supportive electronics than would have been found in even the most advanced medical research centers of the last century, implant manufacturers use 20th century techniques for quality control and manufacturing on the implants these same surgeons place inside us.

It appears that the medical community is just as unaware of the quality disconnect as they are of the actual cost of that implant. In a recent survey sample of 500 orthopedic...

March 3rd, 2014

         Hugo Campos and Amy Tenderich

                        Patient advocates Hugo Campos and Amy Tenderich

 In the era of Big Data, medical devices and hospitals will collect and analyze vast amounts of information in an effort to improve patient outcomes and reduce healthcare costs. But this impending influx of information is creating a data dilemma that medtech needs to resolve as the growing number of empowered patients fight for the right to access their medical device data.

“[With] implantable cardiac devices, medical device companies don’t look at patients as their customers; the patient...

February 28th, 2014